CMPX
NASDAQ · Biotechnology

Compass Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$1.96
+0.19 (+10.73%)
As of May 9, 1:37 AM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 19 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +2,643.4% upside
Low Target $36.32
Average Target $53.77
High Target $66.75
Current Price $1.96
Current
$1.96
Target
$53.77
$36.32 $53.77 avg $66.75
Scenario Analysis
Bear Case
$36.32
1,753.1%
Low target
Base Case
$53.77
+2,643.4%
Avg target
Bull Case
$66.75
+3,305.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.88
-71.5% from high
52-Week Low
$1.61
+21.7% from low
Target vs 52W High
$53.77
+681.5% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $-0.10
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%